|
NCI/FDA Memorandum of Understanding for Proteomics
|
Research Initiative
|
FDA
|
NCI
|
This Memorandum of Understanding (MOU), signed in 2007 and renewed in 2012, establishes an official relationship in clinical proteomic regulatory science between NCI''s Office of Cancer Clinical Proteomics Research and the FDA. Active areas of research collaboration include sample collection, preparation, storage and processing; bioinformatics and data analysis; discovery and validation of biomarkers; and surrogate biomarkers of cancer development and drug response, including standardization among technology platforms and assay standards development.
|
|
NEI Stem Cell Meeting: Clinical Applications of Stem Cell Therapies for Patients with Eye Disease
|
Meeting/ Workshop
|
FDA
|
NEI
|
Stem cells have the potential to treat many diseases, including eye diseases. On December 5-6, 2016, the National Eye Institute (NEI) convened 75 leading stem cell researchers, clinicians, and relevant stakeholders from private foundations, the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), to discuss the state of the science, progress, challenges, and the pathways necessary to translate the science and technology of stem cells to clinical trials for therapy. Cell types discussed included bone marrow (BMSCs), adult stem cells, embryonic (ESCs), corneal limbal stem cells, neural, and retinal progenitors and induced pluripotent stem cells (iPSCs).
|
|
Networking and Information Technology Research and Development (NITRD)
|
Research Initiative
|
AHRQ
|
NIGMS
|
The Networking and Information Technology Research and Development (NITRD) Program provides a framework in which many Federal agencies come together to coordinate their networking and information technology (IT) research and development (R&D) efforts.
|
|
New Molecular Methods for Evaluation of Antibody Responses Following RSV Vaccination and Infection
|
Other
|
FDA
|
NIAID
|
The goal of the project is to identify the key protective epitopes in F and G membrane proteins and to develop new tools to measure virus neutralization and antibody affinity.
|
|
Newborn Screening Coding and Terminology Guide
|
Resource Development
|
CDC, HRSA, OS
|
NLM, NHGRI, NHLBI, NICHD
|
This ongoing collaboration develops, supplements, and publicizes a free online resource with guidance to help promote the efficient electronic exchange of standardized newborn screening data. Related efforts include studying the screening process for diseases including severe combined immunodeficiency (SCID), lysosomal storage disorders (LSDs), and critical congenital heart disease (CCHD), and developing standard codes for ordering and reporting the results of newborn screening for SCID, CCHD, and other conditions added to the Uniform Recommended Screening Panel by the Secretary’s Advisory Committee on Heritable Disorders in Newborns and Children.
|
|
Newborn Screening Federal Partners Committee
|
Committee, Work group, Advisory group, or Task Force
|
AHRQ, CDC, FDA, HRSA
|
NICHD, NHLBI, NLM
|
The National Institutes of Health, Health Resources and Services Administration, Centers for Disease Control and Prevention (CDC), the American College of Medical Genetics and the Genetic Alliance meet monthly, in person or online, to discuss and coordinate current activities and initiatives in newborn screening. Topics include the activities of the Newborn Screening Translational Research Network Coordinating Center, the Clearinghouse of Newborn Screening Information, Sickle Cell Screening Programs, the CDC Newborn Screening Quality Assurance Program, and the Regional Newborn Screening Collaboratives.
|
|
NEWSteps Steering Committee
|
Committee, Work group, Advisory group, or Task Force
|
HRSA
|
NICHD
|
This steering committee supports the mission of NEWSteps, which is to achieve the highest quality for newborn screening systems by providing relevant, accurate tools and resources and to facilitate collaboration between state programs and other newborn screening partners.
|
|
NEXT Longitudinal Study 2009-2016: Health Behavior in School-Age Children
|
Research Initiative
|
HRSA
|
NICHD, NHLBI, NIAAA, NIDA
|
NEXT is a 7-year longitudinal assessment of a representative sample of US adolescent and young adults starting at grade 10. The goals of the study are to identify the trajectory of adolescent health status and health behaviors; to examine predictors of key adolescent risk behaviors; to identify factors that promote or sustain positive health behaviors; to identify transition points in health risk and risk behaviors; and to examine the role of potential gene-environment interactions.
|
|
NGSP (formerly the National Glycohemoglobin Standardization Program)
|
Resource Development
|
CDC
|
NIDDK
|
The purpose of the NGSP (formerly the National Glycohemoglobin Standardization Program) is to standardize Hemoglobin A1c test results to those of the Diabetes Control and Complications Trial (DCCT) and the United Kingdom Prospective Diabetes Study (UKPDS), which established the direct relationships between HbA1c levels and outcome risks in patients with diabetes.
|
|
NIAID Universal Influenza Vaccine Working Group
|
Committee, Work group, Advisory group, or Task Force
|
CDC, OS
|
NIAID
|
HHS working group established to facilitate the development of universal influenza vaccines and move them toward clinical trials.
|